Effect of EMDR in the Treatment of Fibromyalgia - Trial NCT06265194
Access comprehensive clinical trial information for NCT06265194 through Pure Global AI's free database. This phase not specified trial is sponsored by Academy of Therapeutic Sciences, Turkey and is currently Completed. The study focuses on Fibromyalgia. Target enrollment is 79 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Academy of Therapeutic Sciences, Turkey
Timeline & Enrollment
N/A
Jan 01, 2015
Mar 01, 2018
Primary Outcome
Fibromyalgia Impact Questionnaire (FIQ),Pittsburgh Sleep Quality Index (PSQI),Trauma Symptom Checklist-40 (TSC-40)
Summary
The goal of this randomized-controlled study is to investigate the impact of EMDR therapy on
 fibromyalgia symptoms, depression, sleep quality, and traumatic stress in fibromyalgia
 patients.
 
 The main questions it aims to answer are:
 
 - Does EMDR become useful in relieving pain and complaints in fibromyalgia patients?
 
 - Is specific EMDR Fibromyalgia Protocol effective of fibromyalgia patients?
 
 - Does EMDR therapy decrease depression, sleep quality and traumatic stress symptoms of
 individuals with fibromyalgia?
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06265194
Non-Device Trial